A detailed history of First Horizon Corp transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, First Horizon Corp holds 147,609 shares of BMY stock, worth $6.4 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares
147,609
Previous 64,428 129.11%
Holding current value
$6.4 Million
Previous $4.31 Million 54.63%
% of portfolio
0.31%
Previous 0.4%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 24, 2025

BUY
$43.31 - $48.98 $3.6 Million - $4.07 Million
83,181 Added 129.11%
147,609 $6.66 Million
Q2 2021

Aug 09, 2021

BUY
$61.91 - $67.42 $10,277 - $11,191
166 Added 0.26%
64,428 $4.31 Million
Q1 2021

May 11, 2021

BUY
$59.34 - $66.74 $120,875 - $135,949
2,037 Added 3.27%
64,262 $4.06 Million
Q4 2020

Feb 11, 2021

BUY
$57.74 - $65.43 $3,406 - $3,860
59 Added 0.09%
62,225 $3.86 Million
Q3 2020

Nov 12, 2020

BUY
$57.43 - $63.64 $3.57 Million - $3.96 Million
62,166 New
62,166 $3.75 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $92.3B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track First Horizon Corp Portfolio

Follow First Horizon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Horizon Corp, based on Form 13F filings with the SEC.

News

Stay updated on First Horizon Corp with notifications on news.